Dept. of Intensive Care, Herlev University Hospital
Herlev, 2730, Denmark
NCT Number: NCT00197886
Norepinephrine is a drug used to increase blood pressure in patients with life-threatening infection. However, norepinephrine may limit the bloodflow to the gut, thereby causing relative lack of oxygen to the cells. This leads to increased formation of lactic acid.
This study examines whether increasing the dose of norepinephrine leads to higher concentrations of lactic acid in the rectum and stomach in patients with life-threatening infection.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Herlev, 2730, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Herlev Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04031573
Infections, Inflammation
Créteil, France
View Trial DetailsNCT05725837
Infections, Inflammation
Colatina, Espírito Santo, Brazil
View Trial DetailsNCT05327881
Infections, Inflammation
Asyut, Egypt
View Trial DetailsNCT07300306
Critical Illness, Disease Attributes
Istanbul, Turkey (Türkiye)
View Trial Details